Paper Review Records
全部论文审稿周期
18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
72
天
Population Reference Data in the Molecular Diagnosis of Pathogenic CAPN3 Variants: Contextual Evidence and Interpretive Limits
作者
Meghan H. Carr; Ehab Y. Harahsheh; Shaymaa Shurrab; Bukola A. Olarewaju; Mayowa A. Osundiji展开收起
作者单位
1. Omics Curation Ltd., Hayes, UK; 2. Department of Neurology, Mayo Clinic, Phoenix, USA; 3. Division of Genetics/Metabolics, McMaster University, Hamilton, Canada; 4. School of Science and Engineering, University of Dundee, Dundee, UK; 5. Department of Clinical Genomics, Mayo Clinic, Phoenix, USA; 6. Prism Biomedical Consulting, Niagara Falls, Canada展开收起
35
天
82
天
Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore
作者
Daan G. J. Linders; Sebastiaan W. R. Dalmeijer; Bo E. Zweedijk; Hamed Abbasi; Danielle Boldewijn; Sjors A. Koppes; Bernd Kremer; Jacobus Burggraaf; Denise E. Hilling; Joost R. van der Vorst; Jinhui Ser; Satoshi Kashiwagi; Maged Henary; Jeroen C. Jansen; Alexander L. Vahrmeijer; Hak Soo Choi; Stijn Keereweer展开收起
作者单位
1. Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands; 2. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; 3. Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 4. Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 5. Centre for Human Drug Research, Leiden, The Netherlands; 6. Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands; 7. Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 8. Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; 9. Center for Inflammation Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; 10. Department of Chemistry, Center of Diagnostics and Therapeutics, Georgia State University, Atlanta, USA展开收起
90
天
Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2− Metastatic Breast Cancer
作者
Chi-Yin Liao; Jincy John; Precious Anyanwu; Manali A. Bhave; Francois-Clement Bidard; Tyler Marquart; Francisco Sapunar; Aarti Chawla; Lindsay A. Williams展开收起
作者单位
1. Eli Lilly and Company, Indianapolis, USA; 2. Winship Cancer Institute of Emory University, Atlanta, USA; 3. Institut Curie, Paris, France展开收起
19
天
80
天
Development of a Point-of-Care Recombinase Polymerase Amplification Assay for Detection of Neisseria gonorrhoeae and Ceftriaxone-Resistance Associated penA Allele 60.001
作者
Xia Sun; Ying Fu; Yi Liu; Qiongyao Liu; Luxia Chen; Jiang Zhu; Xu’ai Lin; Hao Cheng; Stijn van der Veen展开收起
作者单位
1. Department of Infectious Diseases of the Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Microbiology, School of Medicine, Zhejiang University, Hangzhou, China; 2. Zhejiang University-University of Edinburgh Institute, School of Medicine, Zhejiang University, Haining, China; 3. Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; 4. Amp-Future Biotech, Changzhou, China; 5. Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; 6. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China展开收起
FAQ
Molecular Diagnosis & Therapy审稿要多久?
截至2026-11-18,CrushSCI 收录了 Molecular Diagnosis & Therapy 的 18 篇完整审稿记录。最快一篇从收稿到录用用了 19 天(Anbalcabtagene Autoleucel: First Approval,2026-07-10 收稿,2026-07-29 录用),最慢一篇用了 120 天;平均 68.8 天,中位数 73.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
